Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,865
archived clinical trials in
Multiple Sclerosis

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
mi
from
Orlando, FL
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Parexel International
mi
from
Baltimore, MD
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Parexel International
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MIND
mi
from
Farmington Hills, MI
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MIND
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Tri-State Mountain Neurology
mi
from
Johnson City, TN
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Tri-State Mountain Neurology
mi
from
Johnson City, TN
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Clinical Trial Network
mi
from
Houston, TX
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Integrated Neurology Services
mi
from
Alexandria, VA
A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Integrated Neurology Services
mi
from
Alexandria, VA
Click here to add this to my saved trials
Teriflunomide Male Transmission Study
Assay of Teriflunomide Concentrations in Males Taking Teriflunomide for Treatment of Multiple Sclerosis and Their Female Sexual Partners
Status: Enrolling
Updated:  12/31/1969
Multiple Sclerosis Treatment Center at Griffin Hospital
mi
from
Derby, CT
Teriflunomide Male Transmission Study
Assay of Teriflunomide Concentrations in Males Taking Teriflunomide for Treatment of Multiple Sclerosis and Their Female Sexual Partners
Status: Enrolling
Updated: 12/31/1969
Multiple Sclerosis Treatment Center at Griffin Hospital
mi
from
Derby, CT
Click here to add this to my saved trials
A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Effect of a Tissue Selective Estrogen Complex on Menopausal Symptoms in Women With MS: A Pilot Trial.
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Effect of a Tissue Selective Estrogen Complex on Menopausal Symptoms in Women With MS: A Pilot Trial.
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Exercise in Multiple Sclerosis
Effects of Exercise on Brain Structure and Function in Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
VA Medical Center
mi
from
Minneapolis, MN
Exercise in Multiple Sclerosis
Effects of Exercise on Brain Structure and Function in Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
USC, Keck School of Medicine
mi
from
Los Angeles, CA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
USC, Keck School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
UC Davis
mi
from
Sacramento, CA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health Sciences Center
mi
from
Denver, CO
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Multiple Sclerosis Treatment Center
mi
from
Derby, CT
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Multiple Sclerosis Treatment Center
mi
from
Derby, CT
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Shepard Center
mi
from
Atlanta, GA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Shepard Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Indiana University MS Center
mi
from
Indianapolis, IN
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Indiana University MS Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Maryland Center for MS
mi
from
Baltimore, MD
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Maryland Center for MS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Wayne State University, Department of Neurology
mi
from
Detroit, MI
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Wayne State University, Department of Neurology
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
The Schapiro Center for MS
mi
from
Golden Valley, MN
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
The Schapiro Center for MS
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Gimbel MS Center at Holy Name Hospital
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Mexico, MIND Imaging Center
mi
from
Albuquerque, NM
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Mexico, MIND Imaging Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Corinne Goldsmith Dickinson Center for MS
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
SUNY Stony Brook
mi
from
Stony Brook, NY
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
SUNY Stony Brook
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Carolinas HealthCare System
mi
from
Charlotte, NC
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinical Foundation
mi
from
Cleveland, OH
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinical Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Ohio State University MS Center
mi
from
Columbus, OH
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Ohio State University MS Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University, MS Center of Oregon, UHS-42
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Physicians
mi
from
Philadelphia, PA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Physicians
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital, Allegheny Neurological Associates
mi
from
Pittsburgh, PA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital, Allegheny Neurological Associates
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
The Neurological Research center, Inc
mi
from
Bennington, VT
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
The Neurological Research center, Inc
mi
from
Bennington, VT
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
MS Hub Medical Group
mi
from
Seattle, WA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
MS Hub Medical Group
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
University of Washington, MS Research Center
mi
from
Seattle, WA
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
University of Washington, MS Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Foothills Medical Center
mi
from
Calgary,
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Foothills Medical Center
mi
from
Calgary,
Click here to add this to my saved trials
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Washington University SOM
mi
from
Saint Louis, MO
Study of Oral Fampridine-SR in Multiple Sclerosis
Double-Blind, Placebo-Controlled, 21-Week, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Washington University SOM
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Los Angeles, CA
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 008
mi
from
New Haven, CT
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 008
mi
from
New Haven, CT
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 1370
mi
from
Baltimore, MD
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 1370
mi
from
Baltimore, MD
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 11
mi
from
Detroit, MI
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 11
mi
from
Detroit, MI
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Albuquerque, NM
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10112
mi
from
Rochester, NY
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10112
mi
from
Rochester, NY
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site 10183
mi
from
Philadelphia, PA
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site 10183
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated:  12/31/1969
Teva Investigational Site
mi
from
Houston, TX
Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.
Open Label Study to Evaluate the Safety of Copaxone® and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated With Copaxone®
Status: Enrolling
Updated: 12/31/1969
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials